BRD4-BD1-IN-3

BRD4-BD1-IN-3

• UNSPSC Description: BRD4-BD1-IN-3 (Compound 4g) is a BRD4-BD1 inhibitor. BRD4-BD1-IN-3 can be used for research of inflammatory disease[1].
• Target Antigen: Epigenetic Reader Domain
• Type: Reference compound
• Related Pathways: Epigenetics
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/brd4-bd1-in-3.html
• Solubility: 10 mM in DMSO
• Smiles: OC(C(OC1=C(C)C(C)=C(OC(C)(CCCCCCCCCCCCCCCC)CC2)C2=C1C)=O)C3=NC4=CC=CC=C4C=C3
• Molecular Weight: 615.88
• References & Citations: [1]Gupta A, Purohit R. Identification of potent BRD4-BD1 inhibitors using classical and steered molecular dynamics based free energy analysis. J Cell Biochem. 2024 Mar;125(3):e30532.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported